Urinary inositol phosphoglycan-P type: Near patient test to detect preeclampsia prior to clinical onset of the disease. A study on 416 pregnant Mauritian women

Journal of Reproductive Immunology

Volumn 101-102, Issue 1, 2014, Pages 148-152

  Dawonauth, Lalita ^a   Rademacher, Laurens ^b   L'Omelette, Arnaud Dominique ^a   Jankee, Sarojini ^a   Lee Kwai Yan, Man Yoon ^a   Jeeawoody, Razgia B ^a   Rademacher, Thomas W ^c  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Diagnostic test; Inositol phosphoglycan P type; Preeclampsia; Screening test; Urinary test

Indexed keywords

CREATININE; GLYCAN; INOSITOL; INOSITOL PHOSPHOGLYCAN P TYPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MAURITIUS; POINT OF CARE TESTING; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE LEVEL; YOUNG ADULT;

DIAGNOSTIC TEST; INOSITOL PHOSPHOGLYCAN-P TYPE; PREECLAMPSIA; SCREENING TEST; URINARY TEST;

ADULT; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INOSITOL PHOSPHATES; LONGITUDINAL STUDIES; MASS SCREENING; MAURITANIA; POINT-OF-CARE SYSTEMS; POLYSACCHARIDES; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84897625477     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.06.001     Document Type: Article

References (12)

1. Burton G.J., Scioscia M., Rademacher T.W. Endometrial secretions: creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia?. J. Reprod. Immunol. 2011, 89(2):118-125.
2. Cetin I., Huppertz B., Burton G., Cuckle H., Gonen R., Lapaire O., et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies?. Placenta 2011, 32(S1):S4-S16.
3. Grill S., Rusterholz C., Zanetti-Dallenbach R., Tercanli S., Holzgreve W., Hahn S., Lapaire O. Potential markers of preeclampsia - a review. Reprod. Biol. Endocrinol. 2009, 7:70.
4. Kunjara S., Wang D.-Y., Greenbaum A.L., McLean P., Kutz A., Rademacher T.W. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG-P type, and relationship to pathophysiological changes. Mol. Genet. Metab. 1999, 68:488-502.
5. Kunjara S., Greenbaum A.L., Wang D.Y., Caro H.N., McLean P., Redman C.W. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol. Genet. Metab. 2000, 69:144-158.
6. Paine M.A., Scioscia M., Williams P.J., Gumaa K., Rodeck C.H., Rademacher T.W. Urinary inositol Phosphoglycan P-type as a marker for the prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Hypertens. Pregnancy 2010, 29(4):375-384.
7. Poonyth L., Sobhee R., Soomaree R. Epidemiology of preeclampsia in Mauritius Island. J. Reprod. Immunol. 2003, 59(2):101-109.
8. Scioscia M., Gumaa K., Whitten M., Selvaggi L.E., Rodeck C.H., Rademacher T.W. Inositol Phosphoglycan P-type in healthy and preeclamptic pregnancies. J. Reprod. Immunol. 2007, 76(1/2):85-90. (Review).
9. Scioscia M., Williams P.J., Gumaa K., Fratelli N., Zorzi C., Rademacher T.W. Inositol phosphoglycans and preeclampsia: from bench to bedside. J. Reprod. Immunol. 2011, 89(2):173-177.
10. Scioscia M., Robillard P.Y., Hall D.R., Rademacher L.H., Williams P.J., Rademacher T.W. Inositol Phosphoglycan P-type in infants of preeclamptic mothers. J. Matern. Fetal Neonatal Med. 2012, 2:193-195.
11. Williams P.J., Gumaa K., Scioscia M., Redman C.W., Rademacher T.W. Inositol Phosphoglycan P-type in preeclampsia: a novel marker?. Hypertension 2007, 49(1):84-89.
12. World Health Organization, UNICEF, UNFPA, World Bank Trends in Maternal Mortality: 1990-2010. WHO, UNICEF, UNFPA and The World Bank Estimates 2012, 1-59. WHO Press, Geneva.